Managing Hazardous Drug Exposures: Information for Healthcare Settings

Details

• Alternative Title:
  NIOSH list of antineoplastic and other hazardous drugs
• Personal Author:
  Hodson, Laura ; Ovesen, Jerald L. ; Couch, James R. ; Hirst, Deborah V. L. ; Lawson, Christina C. ; Lentz, Thomas J. ; MacKenzie, Barbara A. ; Mead, Kenneth R.
• Corporate Authors:
  National Institute for Occupational Safety and Health
• Description:
  This document contains risk management information and a Table of Control Approaches describing some of the possible scenarios that workers may encounter in healthcare settings when handling hazardous drugs. The potential exposure of workers from handling a hazardous drug depends on several factors unique to each work setting. Such factors include (1 the dosage form of the drug, (2 the routes of exposure, (3 the frequency, duration, and magnitude of exposure, (4 work practices, and (5 the presence or absence of any exposure controls such as engineering controls, administrative controls, or personal protective equipment (PPE). The National Institute for Occupational Safety and Health (NIOSH encourages healthcare settings to conduct a facility-specific assessment to determine the most effective exposure control strategies for controlling the risks identified in the assessment. Healthcare facilities should repeat these assessments when operating procedures are modified, new controls are put in place, the volume of patients or drug-handling activities increase compared to the baseline, new drugs enter the workplace, hazardous-drug-related injuries occur, illnesses or near-miss incidents are reported, or when deviations from assigned control practices are identified.
  
  In Chapter 8 of this document, there is a Table of Control Approaches for Safer Handling of Hazardous Drugs, which was derived from the table Personal Protective Equipment and Engineering Controls for Working with Hazardous Drugs in Healthcare Settings (often referred to as Table 5), published in previous iterations of the The NIOSH List of Antineoplastic and Other Hazardous Drugs. That table, referred to here as the Table of Control Approaches, provides information for some of the possible scenarios that workers may encounter in healthcare settings when handling hazardous drugs.
  
  
• Content Notes:
  Series Name added retrospectively to efficiently organize past and current materials related to the "NIOSH List of Hazardous Drugs in Healthcare Setting." The Series Name does no appear on the document.
• Subjects:
  Antineoplastic Agents Hazardous Substances Health Facilities Health Personnel Occupational Exposure Poisoning/prevention & Control
• Keywords:
  Antineoplastic Agents Hazardous Drugs Health Care Occupational Exposure Personal Protective Equipment PPE Risk Management
• Series:
  Hazardous Drugs in Healthcare Settings   ; NIOSH Numbered Publications  
• DOI:
  https://doi.org/10.26616/NIOSHPUB2023130
• Publisher:
  National Institute for Occupational Safety and Health
• Document Type:
  Text
• Genre:
  Pamphlet (or booklet)
• Place as Subject:
  United States
• Rights:
  Public Domain
• CIO:
  National Institute for Occupational Safety and Health (NIOSH)
• Division:
  DSI - Division of Science Integration ; DFSE - Division of Field Studies and Engineering
• Topic:
  Workplace Safety & Health
• Location:
  North America
• Pages in Document:
  76 pdf pages
• NIOSHTIC Number:
  nn:20067397
• Citation:
  NIOSH [2023]. Managing hazardous drug exposures: information for healthcare settings. By Hodson L, Ovesen J, Couch J, Hirst D, Lawson C, Lentz TJ, MacKenzie B, Mead K. Cincinnati, OH: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No. 2023-130, https://doi.org/10.26616/NIOSHPUB2023130
• Federal Fiscal Year:
  2023
• Collection(s):
  National Institute for Occupational Safety and Health
• Main Document Checksum:
  urn:sha-512:3b1bc52c874f5e759467236b4665aed296376097ec673a34436620de3d6bcc3f8e6996e15d610877e32071faa5c742341ff8bfaf1e13ed88946b16b191523142
• Download URL:
  https://stacks.cdc.gov/view/cdc/127519/cdc_127519_DS1.pdf
• File Type:
  [PDF - 2.42 MB ]